BlossomHill Therapeutics, Inc. (BLSM) vs Delcath Systems, Inc. (DCTH)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and Delcath Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BLSM vs DCTH

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)DCTH +20.8% (+20.8%/yr)BLSM compounded faster over this window
100120140160Start $100$125$121
BLSM DCTH

BLSM vs DCTH: by the numbers

  • •BLSM is the larger company ($580M vs $548M market cap).
  • •DCTH is profitable (0.56% net margin) while BLSM runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBLSMDCTH
P/E ratioN/A1220.77
P/S ratioN/A5.74
P/B ratioN/A4.52
FCF yieldN/A3.20%

Profitability

MetricBLSMDCTH
Gross margin0.00%87.05%
Operating margin0.00%-1.90%
Net margin0.00%0.56%
ROEN/A0.44%
ROIC-43.41%-0.81%

Growth (annualized)

MetricBLSMDCTH
Revenue CAGR (5Y)N/A118.96%
Total return CAGR (5Y)N/A10.90%

Frequently asked

Is BLSM or DCTH more profitable?
DCTH runs the higher net margin — BLSM at 0.00% versus DCTH at 0.56%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.